UnitedHealth Q1 Earnings Beat, Outlook Raised

UnitedHealth Group reported first-quarter earnings on April 21, 2026, that exceeded analyst expectations, prompting the company to raise its full-year adjusted earnings-per-share (EPS) guidance. Management attributed the outlook boost to easing medical-cost trends, favorable reserve development, and stronger operating cash flow.

Earnings Beat and Raised Guidance

UnitedHealth said in a press release that first-quarter revenue reached $111.7 billion, up 2.0% from $109.6 billion a year earlier and above consensus estimates of $109.2 billion to $109.7 billion. Adjusted EPS came to $7.23, surpassing analyst projections between $6.57 and $6.61. Earnings from operations totaled $9.0 billion, representing a 5.6% net margin. Operating cash flow was $8.9 billion, about 1.4 times net income, while the debt-to-capital ratio stood at 42.9% as of March 31, 2026. These results supported management’s decision to raise full-year adjusted EPS guidance to above $18.25, up from the prior target of more than $17.75.

Medical-Cost Trends and Segment Performance

The company’s medical care ratio (MCR)—the share of revenue spent on medical claims—fell to 83.9%, a 90-basis-point improvement from the prior year and well below consensus estimates near 85.5% to 85.7%. UnitedHealth attributed the decline mainly to strong medical-cost management and favorable reserve development. The company said this improvement was central to margin gains during the quarter.

At the segment level, UnitedHealthcare reported $5.7 billion in earnings from operations, with a 6.6% margin compared with 6.2% a year earlier. Optum’s operating earnings declined to $1.2 billion from $1.3 billion, pressured by a drop in adjusted pharmacy scripts to 383 million from 408 million. Despite this, the insurer unit’s margin expansion helped offset the softness in Optum’s results.

Membership in government programs declined during the quarter. Medicare Advantage enrollment fell by 965,000 to 7.555 million, while Medicaid membership dropped by 220,000 to 7.160 million. The company disclosed these subscriber counts alongside its operating results.

UnitedHealth also completed a portfolio move by selling its Optum UK business in the quarter, directing $400 million of net proceeds to the UnitedHealth Foundation. About two weeks before the earnings release, federal authorities finalized a 2.48% increase in Medicare Advantage payment rates for 2027, which the company cited as a factor supporting its stronger outlook.

“The year-over-year decrease [in MCR] was driven by strong medical cost management and favorable reserve development, partially offset by...” the company said in its earnings release.

Management further discussed medical-cost control, premium repricing, and investment priorities during the earnings call.